Junyi Dai - 23 Mar 2026 Form 3 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Reporting relationship: Chief Executive Officer
Issuer ticker: INDP
Reported as of: 23 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 02 Apr 2026, 19:15:30 UTC
Prior SEC filing: 14 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Junyi Dai

Key filing fact

Junyi Dai filed Form 3 for Indaptus Therapeutics, Inc. (INDP) on 02 Apr 2026.

Key facts

This page summarizes Junyi Dai's Form 3 filing for Indaptus Therapeutics, Inc. (INDP).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Apr 2026, 19:15.

Change

Previous filing in this sequence was filed on 14 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002022463 Primary reporting owner

Dai Junyi

Relationship: Chief Executive Officer
Address: C/O INDAPTUS THERAPEUTICS, INC, 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK
Signature: /s/ Junyi Dai
Signature date: 02 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INDP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,250,000
Date: 23 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On March 19, 2026, Junyi Dai (the "Reporting Person"), the other purchasers named therein and David Elliot Lazar (the "Seller") entered into a securities purchase agreement pursuant to which the Reporting Person acquired an aggregate of 75,000 shares of the Issuer's Series AAA Convertible Non-Redeemable Preferred Stock (the "Series AAA Preferred Stock"). Each share of Series AAA Preferred Stock is convertible into 150 shares of the Company's common stock, $0.01 par value per share (the "Common Stock"). Following the closing of such transaction which occurred on March 23, 2026, the Reporting Person submitted a notice of conversion with respect to all shares of Series AAA Preferred Stock held by the Reporting Person, resulting in the issuance of an aggregate of 11,250,000 shares of Common Stock.